DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Burris 3rd HA et al.
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
J Clin Oncol 1997;
15 (06) 2403-2413
We do not assume any responsibility for the contents of the web pages of other providers.